Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 29 | 41 | 21 | 0 | 0 |
| Gross Profit | 29 | 41 | 21 | N/A | N/A |
| Operating Expenses | 3,508 | 2,141 | 1,049 | 0 | 0 |
| Operating Income | -3,479 | -2,100 | -1,028 | N/A | N/A |
| Other Income | -93 | -86 | -68 | 0 | 0 |
| Pre-tax Income | -3,572 | -2,186 | -1,096 | 0 | 0 |
| Income Tax | -5 | 7 | 10 | N/A | N/A |
| Net Income Continuous | -3,567 | -2,193 | -1,106 | N/A | N/A |
| Net Income | $-3,567 | $-2,193 | $-1,106 | $N/A | $N/A |
| EPS Basic Total Ops | -1.33 | -0.97 | -0.49 | N/A | N/A |
| EPS Basic Continuous Ops | -1.33 | -0.97 | -0.49 | N/A | N/A |
| EPS Diluted Total Ops | -1.33 | -0.97 | -0.49 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.33 | -0.97 | -0.49 | N/A | N/A |
| EBITDA(a) | $-3,470 | $-2,098 | $-1,028 | $N/A | $N/A |